Local Institution - 0121

Hamilton, Ontario L8V 5C2

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma — Running, not enrolling